
Loading, please wait...

Loading, please wait...

Punjab Chief Minister Bhagwant Mann recently announced a significant upgrade for the Advanced Cancer Institute in Bathinda. Specifically, this move aims to modernize treatment methods by introducing robotic surgery in oncology at the earliest opportunity. During his visit, the Chief Minister emphasized the urgency of integrating advanced technology to improve patient outcomes. Therefore, this initiative marks a pivotal shift in how the state handles complex surgical cases. Moreover, it addresses the growing demand for specialized medical care in the region.
Modern technology offers surgeons enhanced precision through high-definition 3D visualization. Consequently, robotic surgery in oncology reduces human error and allows for more stable movements. Additionally, patients often experience less blood loss and smaller incisions compared to traditional open surgery. Furthermore, these minimally invasive techniques typically lead to shorter hospital stays. Similarly, faster recovery times allow patients to resume their daily lives sooner. Because of these benefits, the institute will soon provide world-class facilities to those who need them most.
Beyond technology, the Chief Minister ordered a complete overhaul of the institute's infrastructure. Currently, the facility faces a significant shortage of personnel, especially in nursing departments. However, the government plans to take prompt action to fill these vacancies immediately. Likewise, several need-based facilities will be introduced to ensure the holistic well-being of patients. Residents who hold Ayushman cards can access these services. Thus, these steps reflect a concerted effort to make high-end cancer care accessible to everyone.
Q1: Who can avail of the new robotic surgery facilities at the Bathinda Cancer Institute?
All patients at the Advanced Cancer Institute can potentially benefit, including Ayushman card holders and beneficiaries of the Mukh Mantri Sehat Yojna.
Q2: Why is the Punjab government introducing robotic surgery in public hospitals?
The government aims to modernize treatment, improve surgical precision, and enhance patient recovery standards to match world-class healthcare centers.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


CM Bhagwant Mann announces robotic surgery and infrastructure upgrades at the Advanced Cancer Institute, Bathinda, to modernize cancer care in Punjab....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today